A Study to Evaluate the Effect of Food on the Pharmacokinetics of BN104 Tablets in Healthy Subjects
Latest Information Update: 25 Aug 2025
At a glance
- Drugs BN 104 (Primary)
- Indications Acute myeloid leukaemia; Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- Sponsors BioNova Pharmaceuticals
Most Recent Events
- 08 Aug 2025 Status changed from not yet recruiting to completed.
- 13 Dec 2024 New trial record